Related Content
August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...
August 28, 2023 
March 24, 2023 — According to the U.S. Food and Drug Administration (FDA), Ascend Laboratories LLC is voluntarily ...
March 24, 2023 
November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the ...
November 14, 2022 
November 17, 2021 — Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline ...
November 17, 2021 
November 9, 2021 — Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE ...
November 09, 2021 
MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients
October 4, 2021 — One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk ...
October 04, 2021 
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT) ...
September 01, 2021 
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart ...
September 01, 2021 
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...
June 21, 2021 
May 15, 2021 — The ADAPTABLE trial found no significant differences in cardiovascular events or major bleeding in ...
May 15, 2021 